**Question:** In patients with head injuries, where there is a rapidly increasing intracranial tension without a hematoma, which drug is the preferred choice for initial management?

**Core Concept:** Intracranial tension refers to the pressure exerted within the cranium, which can be influenced by factors such as increased cerebrospinal fluid (CSF) production, decreased CSF absorption, or cerebral edema. Rapidly increasing intracranial tension can lead to severe neurological impairment and potential life-threatening complications.

**Why the Correct Answer is Right:** For patients with head injuries and rapidly increasing intracranial tension without a hematoma, the preferred drug choice is **Option C: Mannitol**. Mannitol is a diuretic that increases osmolality, causing increased water excretion and a subsequent reduction in cerebral edema. This helps to lower the intracranial pressure and protect the patient's brain from further damage.

**Why Each Wrong Option is Incorrect:**

**Option A (Hypotensive therapy):** Hypotensive therapy involves reducing blood pressure to decrease the intracranial pressure. However, this approach could lead to cerebral ischemia and compromise the patient's brain perfusion, which might exacerbate the injury rather than improve it.

**Option B (NSAIDs):** Nonsteroidal anti-inflammatory drugs (NSAIDs) are primarily used for pain and inflammation management, not for addressing intracranial tension. They do not directly influence cerebral edema or intracranial pressure.

**Option D (Diuretics):** Although diuretics can help reduce fluid volume, the specific focus on rapidly increasing intracranial tension requires a drug with a targeted effect on cerebral edema, such as mannitol.

**Clinical Pearl:** In cases of rapidly increasing intracranial tension without a hematoma, the goal of therapy is to reduce cerebral edema to protect brain tissue and prevent further injury. Mannitol is the preferred choice due to its direct effect on cerebral edema, ensuring it is the correct answer.

**Correct Answer:** **Option C (Mannitol)** is the appropriate choice for managing rapidly increasing intracranial tension without hematoma. Mannitol directly reduces cerebral edema, protecting brain tissue from further injury. Hypotensive therapy (Option A) can lead to cerebral ischemia, NSAIDs (Option B) are ineffective for intracranial tension, and diuretics (Option D) lack the specific focus on cerebral edema.